Send me a link:

*Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.00%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.09 Down 0.02(0.64%) 9:30AM EDT - Nasdaq Real Time Price
Prev Close:3.11
Open:N/A
Bid:2.55 x 100
Ask:3.40 x 1300
1y Target Est:10.00
Beta:2.4
Next Earnings Date:N/A
Day's Range:3.09 - 3.09
52wk Range:2.75 - 5.50
Volume:713
Avg Vol (3m):133,487
Market Cap:70.07M
P/E (ttm):N/A
EPS (ttm):-0.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCDown 0.64%70.07M
AZNUp 0.12%94.03B
JNJDown 0.22%288.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):55.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Jun-14) :-0.30
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback